ArticlePituitary2012

First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment.

S Baldari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.